BOLD Shares Outstanding History



Below is a table of the BOLD shares outstanding history going back to 7/20/2016:

Date BOLD Shares Outstanding
7/20/201621.02M
8/31/201621.73M
11/8/201621.73M
3/8/201721.89M
5/9/201727.73M
8/8/201727.78M
11/9/201729.86M
3/5/201836.67M
5/7/201836.74M
8/3/201837.33M
10/31/201842.69M
2/25/201943.59M
5/3/201944.29M
8/1/201945.44M
11/4/201945.78M

Also see: BOLD Market Cap History
BOLD YTD Return
BOLD Historical Shares Outstanding:
+26.67% CAGR
BOLD Historical Shares Outstanding: +26.67% CAGR

Mouse over chart for data details
7/20/2016 ...11/4/2019
Audentes Therapeutics is a clinical stage biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Co. has a portfolio of product candidates, including AT132 for the treatment of X-Linked Myotubular Myopathy, AT845 for the treatment of Pompe disease, AT342 for the treatment of Crigler-Najjar Syndrome, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia. Co. focuses on the treatment of rare diseases caused by single gene, or monogenic, defects in DNA that can be addressed using gene therapy. We show 15 historical shares outstanding datapoints in our coverage of BOLD's shares outstanding history.

Understanding the changing numbers of BOLD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BOLD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BOLD by allowing them to research BOLD shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree BOLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Audentes Therapeutics (BOLD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BOLT Shares Outstanding History
BPMC Shares Outstanding History
BPTH Shares Outstanding History
BRKR Shares Outstanding History
BRTX Shares Outstanding History
BSGM Shares Outstanding History
BSPM Shares Outstanding History
BSTC Shares Outstanding History
BSX Shares Outstanding History
BTAI Shares Outstanding History
More Healthcare companies »

 

BOLD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.